Industry / Germany
Drug Discounts Criticised
February 2008 | Industry NewsGermany's drug discount contracts have come under fire from the German Association of Medicines Manufacturers (BAH), which claims that they are anti-competitive and will hurt small to medium sized enterprises - a view with which
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
